-
Apollo funds complete acquisition of Emerald for $5.03/share; stock delisted from NYSE
Emerald stockholders receive $5.03 per share in cash; stock ceases trading on NYSE.
-
Apollo Funds acquire Emerald (EEX) for $5.03/sh (42% premium); combine with Questex
Emerald stockholders to receive $5.03/sh cash, a 42.1% premium to unaffected price as of Dec 15, 2025.
-
Emerald Q4 rev $132.7M (+24% YoY), FY Adj EBITDA $127.1M (+25%); guides FY2026 rev $490-495M
FY2025 revenue $463.4M (+16.2% YoY); net loss $30.7M vs net income $2.2M prior year, due to contingent consideration remeasurement.
-
Emerald Holding begins strategic review after acquisition inquiries; reaffirms FY2025 guidance
Board evaluating strategic options after receiving multiple acquisition inquiries; Goldman Sachs lead advisor.
-
Emerald Q3 revenue up 6.7% but organic down 6.8%; raises full-year guidance after Generis acquisition
Q3 revenue $77.5M (+6.7% YoY); net loss $14.4M vs $11.1M loss prior year.
-
Emerald X refinances $515M term loans with lower interest margins; 25bps stepdown possible
New term loans bear Base+2.25% or Term SOFR+3.25%, down from prior margin; additional 25bps cut if Moody's rating B1 or better.
-
Emerald acquires Generis Group for ~$60M, adding 17 executive summits
Acquired 100% equity of Generis Group, a B2B executive summit leader, for approx. $60M plus contingent earn-outs.
-
Emerald Q2 revenue up 23% to $105.5M; Adj EBITDA up 60% to $24.4M; reaffirms FY guidance
Revenues $105.5M, +22.7% YoY; organic rev $80.2M, +0.4% (pro forma 4.6% including acquisitions).
-
Emerald Q1 revenue up 10.7% to $147.7M, Adj EBITDA up 31.4% to $53.6M; reaffirms FY guidance
Revenue $147.7M (+10.7% YoY); net income $15.3M ($0.08 diluted) vs $11.0M prior.
-
Emerald FY2024 rev $398.8M, net income $2.2M; acquires events for ~$160M; 2025 rev guidance $450-460M
Full-year 2024 revenue $398.8M (+4.2% YoY); net income $2.2M vs. net loss $8.2M in 2023.
-
Emerald Q3 net loss $11.1M; organic revenue down 5.3%; discontinues 20 events
Revenues $72.6M flat YoY; organic revenues $58.7M down 5.3%.
-
Emerald Q2 2024: Revenue $86M (-0.6%), net loss narrows to $2.8M; initiates $0.015 dividend
Revenues $86.0M, down 0.6% YoY; organic revenues up 3.3% to $82.1M.
-
Emerald Q1 revenue up 9.1% to $133.4M, net income $11.0M; reaffirms FY2024 guidance
Revenue $133.4M (+9.1% YoY); net income $11.0M vs $7.1M; adj. EBITDA $40.8M vs $36.5M.
-
Emerald Holding to convert all Series A Preferred into common on May 2; shares to more than triple
Mandatory conversion triggered by common stock closing above $6.16 for 20 consecutive trading days.
-
Emerald reports FY2023 revenue $382.8M (+17.5%); guides FY2024 revenue $415-425M
Revenue $382.8M, up 17.5% YoY; organic revenue up 14.5% to $370.1M.
-
Emerald Q3 revenue up 16% to $72.5M; cuts FY guidance to $385-395M rev, $95-100M EBITDA
Revenue $72.5M (+16% YoY); Organic revenue $68.5M (+22%). Core trade show strong, content weak.
-
Emerald Q2 revenue $86.5M (+21% YoY); net loss $8.1M; reaffirms FY revenue >$400M
Revenue of $86.5M, up 21.1% YoY; Organic Revenue $79.2M, up 11.1%.
-
Emerald extends term loan maturity to 2026; rate jumps to SOFR+5%+0.10%
Maturity extended from May 2024 to May 2026 on ~$415M term loan.
-
Emerald extends term loan maturity to 2026, raises interest rate to SOFR+5.00%+0.10%
Extended term loan maturity from May 2024 to May 2026; $415M principal unchanged.
-
Emerald Q1 revenue +24% to $122.3M, net income down 56%; reaffirms FY guidance >$400M revenue
Revenue $122.3M (+24.2% YoY); organic revenue +17.0% to $122.1M on strong trade show attendance.
-
Emerald reports FY22 revenue $325.9M (+124% YoY); guides FY23 revenue >$400M
FY22 revenue $325.9M (+124% YoY); net income $130.8M vs loss $79.7M in 2021.
-
Emerald X extends $100M revolver to 2026, prepays $100M term loans
Extended $100.375M revolver maturity to May 23, 2026; terminated remaining $9.625M revolver commitments.
-
Emerald Q3 organic rev +33.5% to $56.6M; net income $93M on $149M insurance settlement
Revenue $62.4M (-18.4% YoY) as prior year had COVID-postponed events; organic revenue $56.6M (+33.5%).
-
Emerald receives final $149.25M insurance litigation settlement, total $372.9M
Received $149.25M from insurance litigation settlement for canceled 2020/2021 events; $148.54M to be recognized as other income in Q3 2022.
-
Emerald Q2 rev $71.4M (+376% YoY); settles insurance litigation for $149.25M
Q2 revenue $71.4M, net loss $0.7M (vs $46.5M loss Q2'21); Adjusted EBITDA $15.6M.
-
Emerald Holding restates Q1 2022 financials; net income overstated by $6.5M
Net income overstated $6.5M due to failure to accrue $5.1M liability for insurance proceeds payable to third party.
-
Emerald Q1 revenue $98.5M, net income $22.6M; guides FY22 revenue >$300M, Adj EBITDA >$50M
Revenue $98.5M (+663.6% YoY); net income $22.6M vs loss $15.3M; diluted EPS $0.07 vs ($0.33).
-
Emerald reports FY2021 net loss of $78.1M; guides FY2022 revenue >$300M
Net loss improved to $78.1M from $633.6M in 2020; revenue $145.5M (+14.2%).
-
Emerald acquires MJBiz for $120M; cannabis B2B platform with $27M revenue in 2021
Base purchase price of $120M in cash; potential earn-out based on 2022 EBITDA growth (9.3x multiple over $13M).
-
Emerald Holding restates financials; material weakness in internal controls over preferred stock accounting
2020 annual and Q1-Q3 2020, Q1-Q2 2021 financials no longer reliable due to Series A Preferred Stock misclassification as permanent equity.
-
Emerald Q3 2021 revenue $76.5M, net loss $9M; restates historical financials
Revenue $76.5M vs $8.5M YoY; net loss $9.0M vs $15.3M; adjusted EBITDA $9.4M vs -$3.2M.
-
Emerald secures $59.8M additional interim insurance payment; total recoveries reach $184.5M
Insurers agreed to pay $59.8M interim: $16.8M for 2020 claims, $43M for 2021 claims.